Nimobent 30 Tablet contains Nimodipine 30 mg, a calcium channel blocker primarily used to prevent and treat cerebral vasospasm following subarachnoid hemorrhage. It works by relaxing cerebral blood vessels, improving oxygen and blood flow to the brain, thereby minimizing the risk of ischemic injury.
This medicine is an essential part of neurology and post-stroke care, often prescribed by neurosurgeons and neurologists to support recovery and reduce complications after aneurysmal bleeding.
Belonging to the cardiology-neurology segment, Nimodipine ensures effective neuroprotection, making Nimobent 30 a highly demanded therapeutic option in hospitals, specialized clinics, and critical care units.
For PCD pharma franchise partners, distributors, and third-party manufacturers, Nimobent 30 Tablet provides a profitable B2B opportunity, with steady prescription demand across India. It is suitable for bulk supply, institutional tenders, exports, and third-party manufacturing.